Are you confused when your thyroid ultrasound report shows terms like "Category 4A" or "Category 5"? Based on the internationally recognized TI-RADS grading system, this tool translates medical imaging reports for category 1-6 nodules (including 4A, 4B, and 4C subcategories) into easy-to-understand risk assessments. Each category corresponds to a specific malignancy probability range (e.g., Category 3 is <5%, Category 4C is 50-80%), helping non-professionals quickly grasp the key information in their reports.
Does a TI-RADS Category 4 require a biopsy?
Not necessarily. Category 4A (5-10% malignancy rate) can often be monitored with follow-ups, while Category 4C (50-80%) generally requires a biopsy.
Does this grading standard apply to all hospitals?
This tool primarily references the ACR (American College of Radiology) TI-RADS standard. Some hospitals may use similar systems like C-TIRADS or the Kwak system, where the definition of Category 4 might slightly differ. We recommend consulting your attending physician with your complete report.
This tool does not replace a clinical diagnosis. If your report indicates Category 4B or higher, or mentions high-risk features like "microcalcifications" or "taller-than-wide shape," please schedule an appointment with a specialist immediately. Special populations, such as pregnant women, require individual assessment and should not base treatment plans solely on grading.
Typical example: An ultrasound describing a "hypoechoic nodule with punctate echogenic foci" usually corresponds to Category 4. Pay attention to the key differences between a "spongiform nodule" (Category 3) and a "solid hypoechoic nodule" (Category 4). For multiple nodules, the assessment should be based on the nodule with the highest risk, not an average.
No comments yet
Be the first to leave a comment!
2022.12-15
